Skip to main content

Table 1 Changes of nutritional, hematological and lipid profile before the start of ND treatment, at, 2, 4 months during the treatment and 2 months after withdrawing treatment in 64 hemodialysis patients.

From: Effect of Nandrolone Decanoate on Serum Lipoprotein (a) and its isoforms in hemodialysis patients

 

Basal (Mean ± SD)

2 months (Mean ± SD)

4 months (Mean ± SD)

ND withdrawal 2 months (Mean ± SD)

Albumin(g/dl)

3.6 ± 0.8

3.9 ± 0.8

4.3 ± 1.0 (p < 0.0001)*

4.0 ± 1.0 (p = 0.001)**

Creatinine(mg/dl)

9.5 ± 3.4

10.7 ± 3.8

11.4 ± 3.4 (p < 0.009)*

10.3 ± 3.4 (p = 0.008)**

Hemoglobin(g/dl)

9.2 ± 2.2

9.9 ± 2.2

10.2 ± 2.1 (p < 0.03)*

9.9 ± 1.8 (p = 0.001)**

Hematocrit (%)

28.2 ± 6.7

30.2 ± 6.6

31.3 ± 6.4 (p < 0.03)*

30.4 ± 5.5 (p = 0.001)**

Cholesterol(mg/dl)

179.4 ± 38.5

196.1 ± 38.8

200.1 ± 39.1 (p = 0.007)*

197.6 ± 35.5 (p < 0.0001)**

HDL-C(mg/dl)

37.5 ± 4.3

36.4 ± 3.7

35.4 ± 3.0 (p = 0.007)*

36.3 ± 3.4 (p = 0.004)**

Triglyceride(mg/dl)

178.7 ± 85.9

180.4 ± 73.3

187.6 ± 70.7 (p < 0.04) ***

181.8 ± 64.6 (p = 0.085)* ***

Lp(a)(mg/dl)

40.6 ± 24.2

33.1 ± 19. 2

31.3 ± 17.2 (p < 0.0001) ***

33.3 ± 21.8 (p < 0.0001)* ***

  1. *, Comparison analysis between base, two and post of treatment values were performed using multiple comparisons by one-way ANOVA. **, Paired t-test was used to assess significancy of differences between base and 2 months after withdrawing treatment. ***, Comparison analysis between base, two and post of treatment values were performed using Friedman test. ****, Wilcoxon signed ranks test was used to assess significancy of differences between the base and 2 months after withdrawing of treatment.